YOLFTbeta
00

Daewoong

003090 · KO · Healthcare / Drug Manufacturers - Specialty & Generic

16,110.00KRW-270.00 (-1.65%)

Price History

Full chart

Market Stats

Previous Close16,380.00
Open16,070.00
Day Range15,820.00 – 16,240.00
52-Week Range15,040.00 – 30,600.00
Volume48.99K
Market Cap655.35B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield1.33%
Beta0.28
50-Day Avg16,788.60
200-Day Avg20,600.05

About

Daewoong Co., Ltd., together with its subsidiaries, engages in the manufacture and sale of pharmaceuticals in South Korea. It is also involved in the real estate rental business; provision of lifestyle-related disease prevention research, business management, public affairs, and facility management services; and processing and sale of food products. The company was formerly known as Daewoong Pharmaceutical Co., Ltd. and changed its name to Daewoong Co., Ltd. in 2002. Daewoong Co., Ltd. was founded in 1945 and is headquartered in Seongnam-si, South Korea.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Yeong-Hwan Yoon
  • Employees404
  • Headquarters244 Galmachi-ro, Seongnam-si, South Korea, Korea
  • Websitehttps://www.daewoongholdings.com

Leadership

  • Mr. Yeong-Hwan YoonChairman and Chief Executive Officer · b. 1934
  • Mr. Nan-Young JeongChief Executive Officer, President and Representative Director · b. 1942

Financials

Income Statement

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue228.63B274.63B278.25B284.29B334.24B413.14B500.88B607.25B695.01B766.64B670.83B294.26B320.77B843.32B893.95B996.76B1.02T1.12T1.23T1.37T1.36T1.51T1.70T1.81T1.94T2.07T
Growth (%)-+20.12%+1.32%+2.17%+17.57%+23.60%+21.24%+21.24%+14.45%+10.31%-12.50%-56.13%+9.01%+162.90%+6.00%+11.50%+1.83%+10.75%+9.53%+10.93%-0.76%+11.51%+12.30%+6.86%+6.79%+6.79%
Cost of Revenue130.04B144.65B139.23B133.18B164.51B214.38B247.39B309.20B432.39B414.06B365.89B172.81B188.10B433.67B512.30B608.66B554.40B609.13B683.60B732.29B728.88B748.20B797.69B882.59B887.99B965.10B
Gross Profit-------------384.12B356.96B388.10B460.61B514.95B547.57B633.47B626.46B763.17B899.65B931.25B1.05T1.10T
Gross Margin-------------45.55%39.93%38.94%45.38%45.81%44.48%46.38%46.22%50.50%53.00%51.34%54.15%53.34%
Operating Expense-------------286.92B278.29B308.44B399.57B430.29B461.92B525.84B528.40B580.55B692.32B735.64B767.02B841.47B
Operating Income32.15B44.46B41.83B33.29B36.07B56.28B77.09B81.51B30.62B97.71B90.24B51.32B43.50B97.20B78.67B79.66B61.04B84.66B85.66B107.63B98.06B182.63B207.33B195.61B281.91B261.79B
Operating Margin14.06%16.19%15.03%11.71%10.79%13.62%15.39%13.42%4.41%12.75%13.45%17.44%13.56%11.53%8.80%7.99%6.01%7.53%6.96%7.88%7.23%12.08%12.22%10.78%14.55%12.66%
EBITDA-----------------142.22B129.43B141.27B205.97B174.23B211.56B270.74B182.13B320.37B
EBITDA Margin-----------------12.65%10.51%10.34%15.20%11.53%12.46%14.93%9.40%15.49%
Net Income16.45B29.42B13.94B7.09B11.91B15.31B24.28B29.63B15.88B20.01B32.36B43.27B44.20B40.77B23.81B38.62B19.83B66.25B29.86B62.44B98.38B78.81B102.57B152.67B57.89B175.06B
Net Income Margin7.19%10.71%5.01%2.49%3.56%3.71%4.85%4.88%2.28%2.61%4.82%14.70%13.78%4.83%2.66%3.87%1.95%5.89%2.43%4.57%7.26%5.21%6.04%8.42%2.99%8.46%
R&D----------4.73B83.27B-16.58B98.79B40.87B112.69B120.55B131.47B123.95B118.85B134.26B169.89B176.60B176.05B186.71B
R&D as % of Total Revenue----------0.71%28.30%-1.97%11.05%4.10%11.10%10.72%10.68%9.08%8.77%8.88%10.01%9.74%9.09%9.03%
Interest Expense0000000000000000009.60B10.10B10.51B10.29B8.35B13.99B7.57B13.87B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.78%0.74%0.78%0.68%0.49%0.77%0.39%0.67%

Balance Sheet

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets340.15B343.38B318.26B318.37B339.21B387.05B452.46B539.93B683.79B706.44B770.12B476.95B509.22B898.47B1.01T1.24T1.47T1.55T1.59T1.67T1.84T1.93T2.16T2.36T2.72T3.23T
Total Liabilities143.55B114.63B112.71B104.39B116.54B135.92B158.29B176.48B271.26B277.06B285.42B140.85B117.83B211.40B302.00B413.82B602.65B609.85B627.86B641.93B720.61B776.67B879.41B922.48B1.22T1.46T
Total Equity171.12B195.00B92.44B124.46B123.89B135.98B155.35B184.66B225.38B240.83B269.67B323.98B361.55B398.03B430.38B465.44B485.84B544.62B569.63B627.63B685.33B730.56B828.83B934.80B996.51B1.18T
Cash22.19B26.54B16.08B30.38B22.88B36.98B45.27B42.23B54.72B56.66B93.19B22.98B41.99B106.26B79.41B100.99B106.21B135.16B95.13B67.46B196.87B124.63B190.44B161.69B191.52B255.92B
Net Debt-----------------249.91B291.72B321.08B242.35B315.63B252.14B283.25B487.04B619.00B

Cash Flow

Currency: KRW2000-12-312001-12-312002-12-312003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow-63.26B32.11B32.97B35.34B38.30B52.24B41.66B56.71B118.04B34.42B10.40B27.62B86.19B46.61B74.92B18.76B147.77B45.38B138.51B145.37B133.18B149.08B205.65B162.38B257.58B
Investing Cash Flow------------6.88B-81.35B-166.21B-117.53B-181.85B-82.53B-79.15B-149.98B-30.79B-219.13B-105.49B---
Financing Cash Flow-------3.12B47.88B-6.65B24.24B-9.01B92.77B63.06B168.74B-34.85B-6.39B-16.48B16.27B11.00B22.57B---
Capital Expenditure012.96B17.52B16.17B14.89B10.31B17.35B40.81B39.55B37.73B71.98B31.06B6.12B25.64B55.76B116.54B174.04B74.63B69.73B53.86B31.95B68.55B68.01B228.96B336.31B347.95B
Free Cash Flow-----------------44.72B-21.70B70.14B80.28B17.67B31.46B-23.30B-173.92B-90.38B
Dividends Paid-3.50B6.68B4.82B5.90B5.89B6.04B6.77B7.30B7.91B8.64B3.44B4.65B8.98B8.74B8.18B8.18B7.68B7.68B7.68B7.64B7.48B8.91B8.12B8.19B12.62B
FCF to OCF-----------------30.26%-47.81%50.64%55.23%13.27%21.10%-11.33%-107.10%-35.09%
Dividend Paid to FCF-----------------17.17%-35.40%10.95%9.52%42.34%28.31%-34.84%-4.71%-13.96%

Earnings

Report DateSep 30, 2009Apr 27, 2010Sep 29, 2010Feb 1, 2011Nov 30, 2011Jan 31, 2012Apr 5, 2012Jul 4, 2012Nov 28, 2012Jan 29, 2013Apr 4, 2013Aug 29, 2013Nov 29, 2013Jan 28, 2014May 30, 2014Aug 29, 2014Dec 1, 2014Jan 27, 2015Apr 2, 2015Jul 1, 2015Dec 2, 2015Feb 2, 2016Jun 29, 2016Nov 30, 2016Mar 31, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Jan 30, 2018May 18, 2018Aug 14, 2018Nov 14, 2018Jan 21, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 19, 2020May 15, 2020Aug 14, 2020Nov 16, 2020May 18, 2021Jul 29, 2021Nov 15, 2021Feb 22, 2022May 16, 2022Aug 16, 2022Nov 14, 2022Feb 15, 2023May 15, 2023Aug 14, 2023Nov 14, 2023Feb 13, 2024May 14, 2024Aug 14, 2024Nov 14, 2024Feb 10, 2025May 15, 2025Aug 12, 2025Nov 12, 2025Feb 9, 2026May 14, 2026Jun 30, 2026
EPS Estimate--------------------------------------289.02244.8254.35375.50375.50425.64415.93512.92589.76960.66614.23--1005.86590.60462.14426.34807.56559.07-----
EPS Actual38.84256.09223.22492.3052.71835.94361.8088.1456.7535.80241.62337.09296.5888.21248.62229.5433.1047.63264.31280.42238.21123.61-63.99227.12333.67295.91283.33326.57628.31334.73294.41325.50-263.11276.64692.13261.62215.48361.00249.00367.0075.00438.00646.00732.00564.00770.00936.00197.00924.00893.00940.00934.54516.00489.001088.00-676.69640.00950.92981.491707.69838.76811.88
Surprise---------------------------------------13.85%49.91%37.99%16.64%72.04%71.98%35.60%50.12%58.71%-79.49%50.43%---7.09%-12.63%5.81%155.20%-183.79%14.48%-----
Timing-----------After-hoursAfter-hours-After-hoursAfter-hoursAfter-hours-------After-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-marketPre-market-Pre-marketPre-marketPre-market-Pre-marketPre-marketPre-marketPre-marketPre-market-

Key Statistics & Ratios

Market Cap655.35B
Enterprise Value1.35T
Trailing P/E0.00
Forward P/E0.00
PEG Ratio0.00
Price / Sales0.31
Price / Book0.53
Revenue (TTM)2.12T
Gross Profit (TTM)1.12T
EBITDA320.94B
Profit Margin8.45%
Operating Margin13.43%
Return on Equity12.89%
Return on Assets4.68%
Shares Outstanding42.04M
Shares Float16.63M
Beta0.28
Dividend Yield1.33%
Dividend Rate200.00
Payout Ratio4.61%

Dividends

20251×
200.00Dec 29, 2025
20241×
200.00Dec 27, 2024
20221×
100.00Dec 28, 2022
20211×
100.00Dec 29, 2021
20201×
100.00Dec 29, 2020
20191×
100.00Dec 27, 2019
20181×
100.00Dec 27, 2018
20171×
100.00Dec 27, 2017
20161×
100.00Dec 28, 2016
20151×
100.00Dec 29, 2015
20141×
100.00Dec 29, 2014
20131×
100.00Dec 27, 2013
20121×
110.00Dec 27, 2012
20111×
106.80Dec 28, 2011
20102×
81.55Dec 29, 2010106.80Mar 30, 2010
20091×
97.09Mar 30, 2009
20081×
97.09Mar 28, 2008
20071×
87.38Mar 29, 2007
20061×
77.67Mar 30, 2006
20051×
72.82Mar 30, 2005
20041×
72.82Mar 30, 2004
20031×
97.09Mar 28, 2003
20021×
121.36Mar 28, 2002

Stock Splits

  • Apr 26, 20175:1
  • Mar 29, 20121.03:1
  • Nov 1, 20020.2:1